Psychometric Evaluation of Quality of Life in a Three-Arm, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-Onset Seizures (EXIST-3)

被引：0
|
作者：
Franz, D.
de Vries, P.
Curatolo, P.
Nabbout, R.
Fan, J.
Neary, M.
Herbst, F.
Sully, K.
Brohan, E.
Lawson, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
25
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 10 条
  • [1] A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures
    Biton, Victor
    Krauss, Gregory
    Vasquez-Santana, Blanca
    Bibbiani, Francesco
    Mann, Allison
    Perdomo, Carlos
    Narurkar, Milind
    EPILEPSIA, 2011, 52 (02) : 234 - 242
  • [2] Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated With Tuberous Sclerosis Complex: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Franz, D.
    Lawson, J.
    Nabbout, R.
    Curatolo, P.
    de Vries, P.
    Berkowitz, N.
    Voi, M.
    Peyrard, S.
    Vaury, A.
    French, J.
    Yapici, Z.
    ANNALS OF NEUROLOGY, 2016, 80 : S316 - S316
  • [3] Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial
    Sperling, Michael R.
    Abou-Khalil, Bassel
    Harvey, Jay
    Rogin, Joanne B.
    Biraben, Arnaud
    Galimberti, Carlo A.
    Kowacs, Pedro A.
    Hong, Seung Bong
    Cheng, Hailong
    Blum, David
    Nunes, Teresa
    Soares-da-Silva, Patricio
    EPILEPSIA, 2015, 56 (02) : 244 - 253
  • [4] Sustained Seizure Reduction With Adjunctive Everolimus for Treatment-Refractory Seizures Associated With Tuberous Sclerosis Complex (TSC): Long-Term Results From the Phase 3 EXIST-3 Study
    Franz, D.
    Lawson, J.
    Yapici, Z.
    Ikeda, H.
    Polster, T.
    Nabbout, R.
    Curatolo, P.
    de, Vries P.
    Dlugos, D.
    Voi, M.
    Fan, J.
    Louveau, A.
    Pelov, P.
    French, J.
    ANNALS OF NEUROLOGY, 2017, 82 : S281 - S282
  • [5] Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures
    Wu, Xun-Yi
    Hong, Zhen
    Wu, Xun
    Wu, Li-Wen
    Wang, Xue-Feng
    Zhou, Dong
    Zhao, Zhong-Xin
    Lv, Chuan-Zhen
    EPILEPSIA, 2009, 50 (03) : 398 - 405
  • [6] Modified titration schedule utilized in the phase 3, randomized, double-blind, placebo-controlled TrustTSC trial evaluating adjunctive ganaxolone for treatment of patients with tuberous sclerosis complex (TSC)-associated seizures
    Flatt, J.
    Koenig, M. K.
    Aimetti, A.
    Miller, I
    Hulihan, J.
    ANNALS OF NEUROLOGY, 2025, 96 : S54 - S55
  • [7] Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures
    Sperling, Michael R.
    Klein, Pavel
    Tsai, Julia
    EPILEPSIA, 2017, 58 (04) : 558 - 564
  • [8] Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study
    Elger, Christian
    Halasz, Peter
    Maia, Joana
    Almeida, Luis
    Soares-da-Silva, Patricio
    EPILEPSIA, 2009, 50 (03) : 454 - 463
  • [9] Efficacy and Safety of Everolimus Based on Prior and Concomitant Antiepileptic Drugs in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-refractory Seizures: Subanalysis of the Phase 3 EXIST-3 Study
    Franz, D.
    Lawson, J.
    Yapici, Z.
    Ikeda, H.
    Polster, T.
    Nabbout, R.
    de Vries, P.
    Dlugos, D.
    Mookerjee, B.
    Fan, J.
    Lixian, J.
    Ridolfi, A.
    Herbst, F.
    French, J.
    ANNALS OF NEUROLOGY, 2018, 84 : S337 - S337
  • [10] BGG492 as an adjunctive treatment in patients with partial-onset seizures: A 12-week, randomized, double-blind, placebo-controlled, phase II dose-titration study with an open-label extension
    Elger, Christian E.
    Hong, Seung Bong
    Brandt, Christian
    Mancione, Linda
    Han, Jackie
    Strohmaier, Christine
    EPILEPSIA, 2017, 58 (07) : 1217 - 1226
1